Stage IVC Squamous Cell Carcinoma of the Larynx Completed Phase 2 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0029837 (Stage IVC Squamous Cell Carcinoma of the Larynx)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02048020Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx CancerTreatment